Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2544-2553

  Shain, Kenneth H ^a   Landowski, Terry H ^a   Dalton, William S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; C FAS ASSOCIATED DEATH DOMAIN LIKE INTERLEUKIN 1 CONVERTING ENZYME LIKE INHIBITORY PROTEIN; CASPASE 8; CASPASE INHIBITOR; ENZYME PRECURSOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FIBRONECTIN; PROCASPASE 8; PROTEIN; REGULATOR PROTEIN; RNA; UNCLASSIFIED DRUG;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; CELL ADHESION; CELL FRACTIONATION; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOSURVEILLANCE; MOLECULAR MECHANICS; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RIBONUCLEASE PROTECTION ASSAY; RNA SYNTHESIS; TUMOR ESCAPE; WESTERN BLOTTING;

EID: 0036499140     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2544     Document Type: Article

References (62)

1. Apoptosis by death factor
2. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity
3. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells
4. Fas-dependent tissue turnover is implicated in tumor cell clearance
5. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy
6. Inhibition of death receptor signals by cellular FLIP
7. The inhibitor of death receptor signaling, FLICE-inhibitory protein, defines a new class of tumor progression factors
8. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
9. CD95 antigen mutations in hematopoietic malignancies
10. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
11. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: Evidence for independent mechanisms of caspase activation
12. Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated, apoptosis in the RPMI 8226 multiple myeloma cell line
13. Mutations in the Fas antigen in patients with multiple myeloma
14. The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance
15. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma
16. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266
17. Myeloma biology and therapy: Present status and future developments
18. Role of interleukin 6 in the growth of myeloma-derived cell lines
19. Interleukin-6 inhibits apoptosis of malignant plasma cells
20. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
21. Adhesion to fibronectin prolongs eosinophil survival
22. 1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: Correlation with Bcl-2 and Bax
23. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin
24. Integrin-mediated cell adhesion activates mitogen-activated protein kinases
25. Signaling by integrin receptors
26. The extracellular matrix as a cell survival factor
27. Disruption of epithelial cell-matrix interactions induces apoptosis
28. p21-activated kinase 1 phosphorylates the -death agonist Bad and protects cells from apoptosis
29. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors
30. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
31. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis
32. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
33. Inhibition of Fas death signals by FLIPs
34. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR 1-induced apoptosis
35. CASH, a novel caspase homologue with death effector domains
36. Casper is a FADD- and caspase-related inducer of apoptosis
37. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
38. Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression
39. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: A role for c-FLIP and implications for anoikis
40. Phosphatidylinositol-3 kinase/Akt activity regulates c-FLIP expression in tumor cells
41. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines
42. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
43. 1 integrin-mediated adhesion correlates with drug resistance in U937 cells
44. Involvement of MACH, a novel Mort1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death
45. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
46. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
47. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal
48. An induced proximity model for caspase-8 activation
49. Cell death attenuation by "Usurpin," a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex
50. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
51. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes
52. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma irradiation
53. Integrin-mediated drug resistance in multiple myeloma
54. kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)
55. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
56. The role of c-FLIP in modulation of CD95-induced apoptosis
57. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the Cd95 death-inducing signaling complex
58. Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization
59. Changes in subcellular distribution of topoisomerase IIα correlate with etoposide resistance in multicell spheroids and xenograft tumors
60. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
61. 14-3-3 Proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
62. L